Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma

Immuno-oncological therapy with checkpoint inhibition (CI) has become a new standard treatment in metastatic renal cell carcinoma (RCC), but the prognostic value of the expression of CI therapy target molecules is still controversial. 342 unselected consecutive RCC tumor samples were analyzed regard...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahlmeyer, Andreas, Stöhr, Christine G., Hartmann, Arndt, Goebell, Peter J., Wullich, Bernd, Wach, Sven, Taubert, Helge, Erlmeier, Franziska
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572544/
https://www.ncbi.nlm.nih.gov/pubmed/31137694
http://dx.doi.org/10.3390/jcm8050743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572544/
https://www.ncbi.nlm.nih.gov/pubmed/31137694
http://dx.doi.org/10.3390/jcm8050743

Ejemplares similares